Advertisement
Research Article Free access | 10.1172/JCI103847
Clinic of General Medicine and Experimental Therapeutics, National Heart Institute, National Institutes of Health, Bethesda, Md.
†Present address: Medical Service, Massachusetts General Hospital, Boston, Mass.
‡Present address: Harvard University, Cambridge, Mass.
*Part of this material has been presented previously (1). The names “metacortandracin” and “metacortandralone” have since been replaced by “prednisone” and “prednisolone.”
Find articles by Pechet, M. in: JCI | PubMed | Google Scholar
Clinic of General Medicine and Experimental Therapeutics, National Heart Institute, National Institutes of Health, Bethesda, Md.
†Present address: Medical Service, Massachusetts General Hospital, Boston, Mass.
‡Present address: Harvard University, Cambridge, Mass.
*Part of this material has been presented previously (1). The names “metacortandracin” and “metacortandralone” have since been replaced by “prednisone” and “prednisolone.”
Find articles by Bowers, B. in: JCI | PubMed | Google Scholar
Clinic of General Medicine and Experimental Therapeutics, National Heart Institute, National Institutes of Health, Bethesda, Md.
†Present address: Medical Service, Massachusetts General Hospital, Boston, Mass.
‡Present address: Harvard University, Cambridge, Mass.
*Part of this material has been presented previously (1). The names “metacortandracin” and “metacortandralone” have since been replaced by “prednisone” and “prednisolone.”
Find articles by Bartter, F. in: JCI | PubMed | Google Scholar
Published April 1, 1959 - More info